Use of glucagon-like peptide-1 receptor agonists might be beneficial for patients with some cancers, research suggests.

SAD-CP, a home-based palliative care program, was shown to effectively meet the care needs of patients with advanced cancer, particularly in underserved areas. A home-based palliative care program was ...

Significantly lower risks seen for those receiving GLP-1 receptor agonists compared with other antidiabetic drugs.

The survey was conducted in May 2025 online (978 participants) and by telephone (30 participants).

Weekend warrior and regular activity patterns meeting current recommendations associated with reduced all-cause, CVD mortality.

Obinutuzumab, a B-cell depleting therapy, is being explored for reducing lupus nephritis risks, such as flare.

A trial testing a nerve-sparing (NeuroSAFE) technique in radical prostatectomy may improve patient-reported outcomes.

The first bladder transplant in a living patient is the successful result of years of research and surgical innovation.

An estimated 3 out of 10 people using cannabis have a cannabis-related disorder, which suggests many are at risk for any adverse health effects.

Childhood cancer survivors have a higher risk of developing severe COVID-19 than the general population, data suggest.

ASCO convened a panel of experts to update the clinical guidelines for fertility preservation in men, women, and adolescents with cancer.

GLP-1 receptor agonists linked to lower medication use and reduced headaches, visual disturbances or blindness, and papilledema.